Companies in the genetics sector developing innovative solutions and technologies.
Explore 352 recently funded genetics companies with verified founder contact information and fundraising data.
Cloverleaf Bio develops an RNA therapeutic platform for oncology.
Tektite Genome is an AI-driven genomics Biotech company that develops and represents non-toxic products and services.
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Science4Beauty develops and sells conotoxin-based skincare products and provides biotechnology services.
iPremom is a healthcare technology company that develops molecular diagnostics for the early detection of pregnancy complications.
Typewriter Therapeutics develops mRNA-based gene therapies using a gene writing platform for site-specific insertion of therapeutic genes.
Helogen Corporation is a space biology and infrastructure company specializing in autonomous orbital laboratories for biomanufacturing.
Codebreaker Labs builds causal genomics data by experimentally mapping genetic variants to cellular effects, powering AI for medicine.
Revier Therapeutics develops small-molecule therapies for cardiometabolic diseases.
Layka Bio is a biotechnology company that offers genetic research, bioinformatics, and precise lab testing for better health.
The Hospital Immune System. Built to stop outbreaks before they start.
Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making.
ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system.
Roslin Technologies is a biotechnology company that focuses on developing technologies for the agricultural and animal health sectors.
Amlogenyx is a novel gene therapeutics company that focuses on developing lysosome-based treatments for Alzheimer's disease.
Cyllene Therapeutics is a French biotechnology business that is pioneering a novel approach termed pinpoint gene therapy.
Inocras provides AI-driven genomic analysis focused on cancer and rare diseases.
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria.
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.
Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.
Thalia Therapeutics is a drug reformulation company.
The genetics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Genetics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The genetics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 352 genetics companies tracked in the VCBacked database.
Companies in the genetics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting genetics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked